This core facility will provide service in DNA cloning, site-directed mutagenesis, overexpression of recombinant apolipoproteins and mutants in E. Coli, and production of gene constructs to produce transgenic mice. Project 1 requires a large number of site-directed mutants of apo-A-I for structural and functional analyses. Project 8 requires construction and overexpression of partial or complete domains of apoB in E. Coli for biophysical studies. Project 10 requires construction of genes to overexpress peptides and apolipoproteins in mice.
Showing the most recent 10 out of 197 publications